Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113651684B reveals a safe, scalable iron-catalyzed oxidation route for 4-hydroxy-2-butynoic acid, offering significant cost reduction in API manufacturing.
Patent CN116496314A details a safer synthesis route for high-purity pharmaceutical intermediates. This method offers substantial cost reduction and enhanced supply chain reliability for global buyers.
Patent CN110845410B reveals a safe one-pot method for 6,7-dimethoxy-3,4-dihydroisoquinoline HCl using phosphotungstic acid, offering high purity and cost reduction.
New patent method for organic semiconductor intermediate. Mild conditions, high yield, cost reduction. Reliable supply for electronic chemical manufacturing and display materials.
Patent CN1358176A reveals a novel synthesis for 2-heterocyclyl methyl benzoic acid derivatives, offering high purity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN104761599B details a novel synthesis route for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with scalable manufacturing.
Patent CN101357927A details a green 7-ANCA synthesis avoiding PCl5 and TFA. This method offers cost reduction in API manufacturing and superior purity for cephalosporin production.
Patent CN110002989B reveals a high-selectivity synthesis for 5-bromo-2-chlorobenzoic acid, offering cost reduction and superior purity for SGLT-2 inhibitor manufacturing.
Patent CN118852050B reveals a novel levamisole intermediate synthesis avoiding DMSO. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101314574B reveals a green aqueous method for acylated enamines using phosphotungstic acid, offering significant cost reduction and scalability for pharmaceutical intermediates.
Novel 8-step route for Bortezomib using isobutylboronic acid, eliminating column chromatography for cost-effective manufacturing.
Patent CN102994403A details a novel whole-cell biocatalytic route for (R)-2-hydroxy-4-phenylbutyric acid ethyl ester, offering superior stereoselectivity and cost efficiency for pharmaceutical manufacturing.
Novel polyionic liquid catalyst enhances yield and reduces waste for phenylpyruvic acid production offering supply chain stability and cost efficiency.
Patent CN112194603B reveals a green oxidation route for key HPPD inhibitor intermediates, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN108752232B details a green photocatalytic method for alpha-quaternary amino acids using CO2, offering safer alternatives to toxic Strecker reactions for pharma supply chains.
Patent CN1119321C details a scalable Reformatsky route for ethyl 3S-amino-4-pentynoate, offering high optical purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel patent method for 2-hydroxyl 3 6-dichlorobenzoic acid reduces pressure requirements and enhances supply chain reliability for agrochemical manufacturers.
Patent CN108059621A details anhydrous butanone purification for 5-Methylpyrazine-2-Carboxylic Acid ensuring high purity and yield for reliable pharmaceutical intermediate supply chains.
Novel green synthesis route for fluoroquinolone intermediates offering high purity and scalable production capabilities for global pharma supply chains.
Patent CN103319358B details a novel route for 7-aminoheptanoic acid. This method ensures stable supply and cost reduction in pharmaceutical intermediates manufacturing.